Capital Insight Partners, LLC Gsk PLC Transaction History

Capital Insight Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 04, 2018	SELL	$39.75 - $42.69 $1.28 Million - $1.38 Million	-32,228 Closed	0 $0
Q2 2018 Jul 05, 2018	BUY	$39.61 - $42.76 $35,054 - $37,842	885 Added 2.82%	32,228 $1.3 Million
Q1 2018 Apr 16, 2018	BUY	$36.18 - $40.15 $129,198 - $143,375	3,571 Added 12.86%	31,343 $1.23 Million
Q4 2017 Jan 12, 2018	SELL	$35.34 - $41.9 $115,102 - $136,468	-3,257 Reduced 10.5%	27,772 $985,000
Q3 2017 Oct 10, 2017	BUY	$39.44 - $41.55 $1.22 Million - $1.29 Million	31,029	31,029 $1.26 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $76.7B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Insight Partners, LLC with notifications on news.